\-\ Texto\\:\\ \ \(0\)\
\-\ there\\ are\\ multiple\\ firm\\ hyperpigmented\\ indurated\\,\\ bound\\ down\\ plaques\\ extending\\ from\\ bilateral\\ inner\\ thighs\\ to\\ bilateral\\ shins\\.\\ \\ \ \(0\)\
\-\ no\\ lab\\ work\\ available\\.\ \(0\)\
\-\ no\\ treatment\\.\ \(2\)\
\-\ biopsy\\:\\ there\\ is\\ a\\ mild\\ perivascular\\ lymphocytic\\ infiltrate\\ with\\ increased\\ density\\ of\\ collagen\\ bundles\\ in\\ the\\ reticular\\ dermis\\.\\ \\ capillaries\\ are\\ reduced\\ in\\ number\\ with\\ atrophy\\ of\\ eccrine\\ glands\\.\ \(0\)\
\-\ nephrogenic\\ fibrosing\\ dermopathy\\/nephrogenic\\ systemic\\ fibrosis\ \(0\)\
\-\ 54\\ yo\\ woman\\ with\\ idiopathic\\ end\\-stage\\ renal\\ disease\\ for\\ four\\ years\\ requiring\\ renal\\ dialysis\\.\\ \\ she\\ presents\\ now\\ with\\ extensive\\ dry\\ and\\ firm\\ areas\\ that\\ started\\ on\\ both\\ anterior\\ shins\\ and\\ rapidly\\ progressed\\ to\\ involve\\ both\\ inner\\ thighs\\,\\ over\\ the\\ past\\ 3\\ months\\.\\ \\ she\\ also\\ complains\\ of\\ some\\ tenderness\\ of\\ the\\ lesions\\ to\\ palpation\\.\\ \\ \ \(0\)\
\-\ pmh\\:\\ six\\ previous\\ gadolinium\\ mr\\ scans\\.\\ \\ \\ \\ \\ \ \(0\)\
\-\ unremarkable\\ family\\ history\\.\ \(0\)\
\-\ nephrogenic\\ fibrosing\\ dermopathy\\ \\(nfd\\)\\ is\\ a\\ rare\\,\\ acquired\\,\\ idiopathic\\ disorder\\ in\\ patients\\ with\\ end\\-stage\\ renal\\ disease\\.\\ \\ clinically\\,\\ patient\\ typically\\ presents\\ with\\ large\\ area\\ of\\ indurated\\,\\ thick\\,\\ sclerotic\\ skin\\ involving\\ the\\ extremities\\.\\ \\ muscle\\ weakness\\ and\\ flexion\\ contractures\\ are\\ also\\ common\\.\\ \\ histologic\\ evaluation\\ reveals\\ increased\\ dermal\\ fibroblasts\\ and\\ elastic\\ fibers\\,\\ with\\ thick\\ collagen\\ bundles\\ and\\ mucin\\ deposition\\.\\ \\ \ \(0\)\
\-\ the\\ pathophysiology\\ of\\ nfd\\ is\\ not\\ known\\.\\ \\ most\\ patients\\ have\\ a\\ history\\ of\\ end\\-stage\\ renal\\ disease\\ requiring\\ hemodialysis\\.\\ \\ most\\ recently\\,\\ there\\ have\\ been\\ reports\\ of\\ nfd\\ associated\\ with\\ previous\\ gadolinium\\ mra\\ scans\\.\\ \\ also\\,\\ there\\ are\\ reported\\ cases\\ following\\ peritoneal\\ dialysis\\,\\ renal\\ transplantation\\,\\ and\\ acute\\ and\\ chronic\\ renal\\ disease\\.\ \(0\)\
\-\ case\\ presented\\ by\\ yang\\ xia\\,\\ m\\.d\\.\\,\\ cpt\\,\\ mc\\,\\ usa\\ at\\ the\\ 2007\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ san\\ antonio\\,\\ tx\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nfd\\:\\ 0\\.09411585506014056\ \(0\)\
\-\ end\\-stage\\:\\ 0\\.06520428707684293\ \(0\)\
\-\ shins\\:\\ 0\\.057810471483320656\ \(0\)\
\-\ renal\\:\\ 0\\.05482154198131109\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.04794360770310791\ \(0\)\
\-\ fibrosing\\:\\ 0\\.04635539737346941\ \(0\)\
\-\ indurated\\:\\ 0\\.04505773504753379\ \(0\)\
\-\ thighs\\:\\ 0\\.04448803606053353\ \(0\)\
\-\ bundles\\:\\ 0\\.042578683842777805\ \(0\)\
\-\ dialysis\\:\\ 0\\.038076743922895166\ \(0\)\
\-\ collagen\\:\\ 0\\.034621172280320786\ \(0\)\
\-\ requiring\\:\\ 0\\.03360266093768254\ \(0\)\
\-\ inner\\:\\ 0\\.03271182006256506\ \(0\)\
\-\ thick\\:\\ 0\\.03192017853153144\ \(0\)\
\-\ dermopathy\\/nephrogenic\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ dermopathy\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ xia\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ firm\\:\\ 0\\.029825947406990936\ \(0\)\
\-\ bound\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ gadolinium\\:\\ 0\\.02884942696917254\ \(0\)\
\-\ scans\\:\\ 0\\.028321968092633595\ \(0\)\
\-\ idiopathic\\:\\ 0\\.02772624553835141\ \(0\)\
\-\ contractures\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ eccrine\\:\\ 0\\.026438519796607142\ \(0\)\
\-\ yang\\:\\ 0\\.02564441463178789\ \(0\)\
\-\ cpt\\:\\ 0\\.024995583468820082\ \(0\)\
\-\ hyperpigmented\\:\\ 0\\.02444700453705048\ \(0\)\
\-\ antonio\\:\\ 0\\.02444700453705048\ \(0\)\
\-\ fibroblasts\\:\\ 0\\.023971803851553956\ \(0\)\
\-\ previous\\:\\ 0\\.02361815088023698\ \(0\)\
\-\ elastic\\:\\ 0\\.023552647141033018\ \(0\)\
\-\ capillaries\\:\\ 0\\.023177698686734704\ \(0\)\
\-\ m\\.d\\.\\:\\ 0\\.023177698686734704\ \(0\)\
\-\ hemodialysis\\:\\ 0\\.022528867523766895\ \(0\)\
\-\ san\\:\\ 0\\.022244018030266766\ \(0\)\
\-\ mucin\\:\\ 0\\.021734762358947644\ \(0\)\
\-\ usa\\:\\ 0\\.021085931195979835\ \(0\)\
\-\ perivascular\\:\\ 0\\.020710982741681518\ \(0\)\
\-\ dermal\\:\\ 0\\.020371800607146554\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.020371800607146554\ \(0\)\
\-\ transplantation\\:\\ 0\\.0202136092812717\ \(0\)\
\-\ disease\\:\\ 0\\.019882384928337424\ \(0\)\
\-\ reticular\\:\\ 0\\.01977730208521358\ \(0\)\
\-\ dermis\\:\\ 0\\.019513572646944106\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.019388692505266987\ \(0\)\
\-\ histologic\\:\\ 0\\.019268046413894457\ \(0\)\
\-\ tx\\:\\ 0\\.018822625976335716\ \(0\)\
\-\ there\\:\\ 0\\.018102712547544322\ \(0\)\
\-\ infiltrate\\:\\ 0\\.018070636319157042\ \(0\)\
\-\ glands\\:\\ 0\\.018070636319157042\ \(0\)\
\-\ dry\\:\\ 0\\.018070636319157042\ \(0\)\
\-\ also\\:\\ 0\\.017985262565873503\ \(0\)\
\-\ mc\\:\\ 0\\.017825110086107397\ \(0\)\
\-\ progressed\\:\\ 0\\.017595435633660523\ \(0\)\
\-\ \\,\\:\\ 0\\.017340858289363603\ \(0\)\
\-\ 2007\\:\\ 0\\.017176278923139585\ \(0\)\
\-\ fibers\\:\\ 0\\.017110979497274116\ \(0\)\
\-\ she\\:\\ 0\\.01707321097120407\ \(0\)\
\-\ mra\\:\\ 0\\.01704685670189092\ \(0\)\
\-\ plaques\\:\\ 0\\.01698386888303184\ \(0\)\
\-\ deposition\\:\\ 0\\.01698386888303184\ \(0\)\
\-\ seminar\\:\\ 0\\.016921976560213804\ \(0\)\
\-\ rapidly\\:\\ 0\\.016861142277796365\ \(0\)\
\-\ uniformed\\:\\ 0\\.016742507330224865\ \(0\)\
\-\ are\\:\\ 0\\.01658183448440714\ \(0\)\
\-\ services\\:\\ 0\\.016408632756496556\ \(0\)\
\-\ dermatology\\:\\ 0\\.016408632756496556\ \(0\)\
\-\ acquired\\:\\ 0\\.016303957008431454\ \(0\)\
\-\ 54\\:\\ 0\\.01605499405965241\ \(0\)\
\-\ reduced\\:\\ 0\\.016007225304022023\ \(0\)\
\-\ peritoneal\\:\\ 0\\.015822315201065754\ \(0\)\
\-\ patients\\:\\ 0\\.015740744479473493\ \(0\)\
\-\ atrophy\\:\\ 0\\.01568967678541724\ \(0\)\
\-\ both\\:\\ 0\\.015531672531573816\ \(0\)\
\-\ number\\:\\ 0\\.015165984100946467\ \(0\)\
\-\ pmh\\:\\ 0\\.015128719688607338\ \(0\)\
\-\ six\\:\\ 0\\.014948035256673447\ \(0\)\
\-\ increased\\:\\ 0\\.014878895244125662\ \(0\)\
\-\ lab\\:\\ 0\\.014878254219704136\ \(0\)\
\-\ bilateral\\:\\ 0\\.014760268536045864\ \(0\)\
\-\ systemic\\:\\ 0\\.014548507492007676\ \(0\)\
\-\ involve\\:\\ 0\\.014334614523788087\ \(0\)\
\-\ work\\:\\ 0\\.01424674045763018\ \(0\)\
\-\ recently\\:\\ 0\\.014189340521936645\ \(0\)\
\-\ complains\\:\\ 0\\.014132851734903583\ \(0\)\
\-\ most\\:\\ 0\\.014041531257851075\ \(0\)\
\-\ flexion\\:\\ 0\\.013995432389253121\ \(0\)\
\-\ disorder\\:\\ 0\\.013661155450341364\ \(0\)\
\-\ sclerotic\\:\\ 0\\.013612405114547194\ \(0\)\
\-\ started\\:\\ 0\\.013564313587263484\ \(0\)\
\-\ fibrosis\\:\\ 0\\.013540509358968833\ \(0\)\
\-\ clinically\\:\\ 0\\.013333146696605932\ \(0\)\
\-\ four\\:\\ 0\\.01320132722443387\ \(0\)\
\-\ have\\:\\ 0\\.013170377781957949\ \(0\)\
\-\ down\\:\\ 0\\.013053466004103363\ \(0\)\
\-\ family\\:\\ 0\\.012463745355603953\ \(0\)\
\-\ presents\\:\\ 0\\.012424514558775272\ \(0\)\
\-\ reports\\:\\ 0\\.012259360839284111\ \(0\)\
\-\ extensive\\:\\ 0\\.012161408264942154\ \(0\)\
\-\ extremities\\:\\ 0\\.011927710387689994\ \(0\)\
\-\ reveals\\:\\ 0\\.01189767882667268\ \(0\)\
\-\ rare\\:\\ 0\\.01180907544011849\ \(0\)\
\-\ skin\\:\\ 0\\.011680174146757928\ \(0\)\
\-\ weakness\\:\\ 0\\.011293990580172187\ \(0\)\
\-\ reported\\:\\ 0\\.011085675624824954\ \(0\)\
\-\ muscle\\:\\ 0\\.010922830012193397\ \(0\)\
\-\ biopsy\\:\\ 0\\.010788943920415517\ \(0\)\
\-\ typically\\:\\ 0\\.010734611279380683\ \(0\)\
\-\ involving\\:\\ 0\\.010670488483997487\ \(0\)\
\-\ now\\:\\ 0\\.01039542914484572\ \(0\)\
\-\ areas\\:\\ 0\\.010232552210840094\ \(0\)\
\-\ extending\\:\\ 0\\.010223199462063334\ \(0\)\
\-\ available\\:\\ 0\\.010223199462063334\ \(0\)\
\-\ palpation\\:\\ 0\\.010149249396256412\ \(0\)\
\-\ cases\\:\\ 0\\.01013099951594709\ \(0\)\
\-\ unremarkable\\:\\ 0\\.010067852023779574\ \(0\)\
\-\ density\\:\\ 0\\.0100058055404269\ \(0\)\
\-\ past\\:\\ 0\\.009662631572763111\ \(0\)\
\-\ mr\\:\\ 0\\.009662631572763111\ \(0\)\
\-\ known\\:\\ 0\\.009622957595956654\ \(0\)\
\-\ area\\:\\ 0\\.009615075601901306\ \(0\)\
\-\ tenderness\\:\\ 0\\.009248798302069868\ \(0\)\
\-\ some\\:\\ 0\\.009234620120522273\ \(0\)\
\-\ yo\\:\\ 0\\.009150717164778511\ \(0\)\
\-\ years\\:\\ 0\\.008929690879069332\ \(0\)\
\-\ evaluation\\:\\ 0\\.00883359002073597\ \(0\)\
\-\ following\\:\\ 0\\.008630881697157112\ \(0\)\
\-\ chronic\\:\\ 0\\.008565799405362989\ \(0\)\
\-\ history\\:\\ 0\\.008400103471224793\ \(0\)\
\-\ months\\:\\ 0\\.008305840906370345\ \(0\)\
\-\ presented\\:\\ 0\\.008289528950257684\ \(0\)\
\-\ been\\:\\ 0\\.008273291421580039\ \(0\)\
\-\ lesions\\:\\ 0\\.008140784720085222\ \(0\)\
\-\ \\:\\:\\ 0\\.008044660612033202\ \(0\)\
\-\ mild\\:\\ 0\\.008008019409007604\ \(0\)\
\-\ common\\:\\ 0\\.007958246305894652\ \(0\)\
\-\ anterior\\:\\ 0\\.00783200293153999\ \(0\)\
\-\ over\\:\\ 0\\.007742500320782784\ \(0\)\
\-\ acute\\:\\ 0\\.00750846736336831\ \(0\)\
\-\ associated\\:\\ 0\\.007176023351984704\ \(0\)\
\-\ 3\\:\\ 0\\.007120909347710105\ \(0\)\
\-\ woman\\:\\ 0\\.007024565649426712\ \(0\)\
\-\ case\\:\\ 0\\.006653040686360394\ \(0\)\
\-\ large\\:\\ 0\\.006649617195128397\ \(0\)\
\-\ multiple\\:\\ 0\\.006405003571100601\ \(0\)\
\-\ treatment\\:\\ 0\\.0061552204968003095\ \(0\)\
\-\ no\\:\\ 0\\.006124157656254818\ \(0\)\
\-\ is\\:\\ 0\\.006003104395566466\ \(0\)\
\-\ that\\:\\ 0\\.005252600457504709\ \(0\)\
\-\ by\\:\\ 0\\.005063597520444394\ \(0\)\
\-\ to\\:\\ 0\\.004559445997611953\ \(0\)\
\-\ from\\:\\ 0\\.004506888658911788\ \(0\)\
\-\ in\\:\\ 0\\.004498902812885284\ \(0\)\
\-\ and\\:\\ 0\\.004484210107208289\ \(0\)\
\-\ not\\:\\ 0\\.004394372497302261\ \(0\)\
\-\ a\\:\\ 0\\.004234161585251971\ \(0\)\
\-\ at\\:\\ 0\\.004120153568795847\ \(0\)\
\-\ with\\:\\ 0\\.00333107974633138\ \(0\)\
\-\ of\\:\\ 0\\.003316834186419599\ \(0\)\
\-\ patient\\:\\ 0\\.0030483698609124125\ \(0\)\
\-\ the\\:\\ 0\\.002951942022141476\ \(0\)\
\-\ for\\:\\ 0\\.0025946909204367084\ \(0\)\
\-\ on\\:\\ 0\\.0025761245991652243\ \(0\)\
\-\ \\(\\:\\ 0\\.0025706822998002154\ \(0\)\
\-\ \\)\\:\\ 0\\.0025392800431078472\ \(0\)\
\-\ \\.\\:\\ 0\\.002400324504802773\ \(0\)\
